Charles River Laboratories (CRL) Tops Q1 EPS by 25c; raises guidance
Tweet
Share
E-mailGet Alerts CRL Hot Sheet
Price: $226.79 --0%
EPS Growth %: -12.5%
Financial Fact:
Net sales related to services: 292.85M
Today's EPS Names:
CRMT, FOMI, FLES, More
EPS Growth %: -12.5%
Financial Fact:
Net sales related to services: 292.85M
Today's EPS Names:
CRMT, FOMI, FLES, More
Join SI Premium – FREE
Charles River Laboratories (NYSE: CRL) reported Q1 EPS of $2.34, $0.25 better than the analyst estimate of $2.09. Revenue for the quarter came in at $984.2 million versus the consensus estimate of $941.47 million.
GUIDANCE:
Charles River Laboratories sees FY2025 EPS of $9.30-$9.80, versus the consensus of $9.31.
For earnings history and earnings-related data on Charles River Laboratories (CRL) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Trump discloses over $1.4 billion in crypto income in 2025 filing
- Nasdaq reports record $129.3B raised in first half of 2026
- General Mills (GIS) Tops Q4 EPS by 14c, Beats on Revenue; Offers FY27 EPS Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
